Slower gait speed, but not handgrip strength or muscle mass, is associated with an increased risk for cardiovascular outcomes ...
AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...
WhiteSwell, a company pioneering a new paradigm in the treatment of acute decompensated heart failure (ADHF), announced today positive data from 21 patients treated in its DELTA-HF trial evaluating ...
As we mentioned last week, February is American Heart Month, but do you know syptoms of heart disease can vary by gender?whether you're a man or woman... heart ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback